source
- China clamps down on investigator-initiated clinical trials, tightening oversightChina has announced tighter oversight of investigator-initiated trials (ITTs), requiring these studies to obtain approval from the National Medical Products Administration before they can begin. Th…
- FDA approves Labcorp's BRAF melanoma companion diagnosticThe FDA has granted approval to Labcorp's companion diagnostic for advanced melanoma patients with specific BRAF mutations. The test, called PGDx elio tissue complete CDx, uses next-generation seq…